JACQUELINE BOODHOO: Open Payments
NPI 1376707562 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,140 in 43 payments from 14 companies in 2025. Trend: 2023 $144 · 2024 $489 · 2025 $1,140
Food & beverage: $1,140
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $195 |
| Braintree Laboratories, Inc. | 3 | $182 |
| Lucid Diagnostics Inc. | 2 | $140 |
| Phathom Pharmaceuticals, Inc. | 4 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $87 |
| GENZYME CORPORATION | 3 | $79 |
| QOL Medical, LLC | 3 | $79 |
| Janssen Biotech, Inc. | 4 | $78 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $46 |
Products named: SUTAB, DUPIXENT, VOQUEZNA, Sucraid, TREMFYA, RINVOQ, ENTYVIO, XIFAXAN.
Industry payments across FL — which companies pay providers there.
